Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
111,633,839
-
Number of holders
-
236
-
Total 13F shares, excl. options
-
111,785,118
-
Shares change
-
+10,958,641
-
Total reported value, excl. options
-
$3,613,805,603
-
Value change
-
+$349,745,862
-
Put/Call ratio
-
366%
-
Number of buys
-
126
-
Number of sells
-
-103
-
Price
-
$32.45
Significant Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q1 2023
280 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock as of Q1 2023.
Evolent Health, Inc. - Class A Common Stock (EVH) has 236 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 111,785,118 shares
.
Largest 10 shareholders include FMR LLC (14,641,699 shares), VANGUARD GROUP INC (9,320,669 shares), BlackRock Inc. (6,928,258 shares), JPMORGAN CHASE & CO (5,560,550 shares), Rock Springs Capital Management LP (3,803,500 shares), Granahan Investment Management, LLC (3,374,911 shares), Invesco Ltd. (3,342,586 shares), ORBIMED ADVISORS LLC (2,895,632 shares), WELLINGTON MANAGEMENT GROUP LLP (2,499,435 shares), and DIMENSIONAL FUND ADVISORS LP (2,492,972 shares).
This table shows the top 236 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.